Acute Cyclooxygenase inhibition does not alter muscle sympathetic nerve activity or forearm vasodilator responsiveness in lean and obese adults

Physiological Reports

Volumn 2, Issue 7, 2014, Pages

  Barnes, Jill N ^a   Charkoudian, Nisha ^b   Matzek, Luke J ^a   Johnson, Christopher P ^a   Joyner, Michael J ^a   Curry, Timothy B ^a  

^a MAYO CLINIC   (United States)

^b U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

Autonomic nervous system; Blood pressure; Forearm blood flow; Inflammation

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; IBUPROFEN; INTERLEUKIN 6; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; BODY MASS; BRACHIAL ARTERY; CELL MEMBRANE CONDUCTANCE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FOREARM BLOOD FLOW; HEART BEAT; HEMODYNAMICS; HUMAN; IMMUNOASSAY; INFLAMMATION; LEAN BODY WEIGHT; MALE; MEAN ARTERIAL PRESSURE; MUSCLE SYMPATHETIC NERVE ACTIVITY; OBESITY; PLETHYSMOGRAPHY; VASODILATATION;

EID: 85002597663     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12079     Document Type: Article

References (37)

1. Alvarez, G. E., S. D. Beske, T. P. Ballard, and K. P. Davy. 2002. Sympathetic neural activation in visceral obesity. Circulation 106:2533-2536.
2. Alvarez, G. E., T. P. Ballard, S. D. Beske, and K. P. Davy. 2004. Subcutaneous obesity is not associated with sympathetic neural activation. Am. J. Physiol. Heart Circ. Physiol. 287:H414-H418.
3. Alvarez, G. E., J. R. Halliwill, T. P. Ballard, S. D. Beske, and K. P. Davy. 2005. Sympathetic neural regulation in endurance-trained humans: fitness vs. fatness. J. Appl. Physiol. 98:498-502.
4. Bardgett, M. E., W. W. Holbein, M. Herrera-Rosales, and G. M. Toney. 2014. Ang II-Salt hypertension depends on neuronal activity in the hypothalamic paraventricular nucleus but not on local actions of tumor necrosis factor-alpha. Hypertension 63:527-534.
5. Charkoudian, N., M. J. Joyner, C. P. Johnson, J. H. Eisenach, N. M. Dietz, and B. G. Wallin. 2005. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J. Physiol. 568:315-321.
6. Cui, J., P. McQuillan, A. Momen, C. Blaha, R. Moradkhan, V. Mascarenhas, et al. 2007. The role of the cyclooxygenase products in evoking sympathetic activation in exercise. Am. J. Physiol. Heart Circ. Physiol. 293:H1861-H1868.
7. Cui, J., R. Moradkhan, V. Mascarenhas, A. Momen, and L. I. Sinoway. 2008. Cyclooxygenase inhibition attenuates sympathetic responses to muscle stretch in humans. Am. J. Physiol. Heart Circ. Physiol. 294:H2693-H2700.
8. Curry, T. B., M. Somaraju, C. N. Hines, C. B. Groenewald, J. M. Miles, M. J. Joyner, et al. 2013. Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. Obesity (Silver Spring) 21:480-485.
9. Doerzbacher, K. J., and C. A. Ray. 2001. Muscle sympathetic nerve responses to physiological changes in prostaglandin production in humans. J. Appl. Physiol. 90:624-629.
10. Grassi, G., G. Seravalle, B. M. Cattaneo, G. B. Bolla, A. Lanfranchi, M. Colombo, et al. 1995. Sympathetic activation in obese normotensive subjects. Hypertension 25:560-563.
11. Grassi, G., G. Seravalle, R. Dell’Oro, C. Turri, L. Pasqualinotto, M. Colombo, et al. 2001. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 38:1316-1320.
12. Hart, E. C., N. Charkoudian, B. G. Wallin, T. B. Curry, J. Eisenach, and M. J. Joyner. 2011. Sex and ageing differences in resting arterial pressure regulation: the role of the beta-adrenergic receptors. J. Physiol. 589:5285-5297.
13. Joyner, M. J., N. M. Dietz, and J. T. Shepherd. 2001. From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J. Appl. Physiol. 91:2431-2441.
14. Kienbaum, P., T. Karlssonn, Y. B. Sverrisdottir, M. Elam, and B. G. Wallin. 2001. Two sites for modulation of human sympathetic activity by arterial baroreceptors? J. Physiol. 531:861-869.
15. de Kloet, A. D., E. G. Krause, P. D. Shi, J. Zubcevic, M. K. Raizada, and C. Sumners. 2013. Neuroimmune communication in hypertension and obesity: a new therapeutic angle? Pharmacol. Ther. 138:428-440.
16. Kuniyoshi, F. H. S., I. C. Trombetta, L. T. Batalha, M. U. P. B. Rondon, M. C. Laterza, M. M. G. Gowdak, et al. 2003. Abnormal neurovascular control during sympathoexcitation in obesity. Obes. Res. 11:1411-1419.
17. Lambert, E. A., N. E. Straznicky, and G. W. Lambert. 2013. A sympathetic view of human obesity. Clin. Auton. Res. 23:9-14.
18. Limberg, J. K., T. D. Evans, G. M. Blain, D. F. Pegelow, J. R. Danielson, M. W. Eldridge, et al. 2012. Effect of obesity and metabolic syndrome on hypoxic vasodilation. Eur. J. Appl. Physiol. 112:699-709.
19. Minson, C. T., J. R. Halliwill, T. M. Young, and M. J. Joyner. 2000. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation 102:1473-1476.
20. Monahan, K. D., and C. A. Ray. 2005. Cyclooxygenase inhibition and baroreflex sensitivity in humans. Am. J. Physiol. Heart Circ. Physiol. 288:H737-H743.
21. Narkiewicz, K., P. J. van de Borne, R. L. Cooley, M. E. Dyken, and V. K. Somers. 1998. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98:772-776.
22. Parepally, J. M., H. Mandula, and Q. R. Smith. 2006. Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm. Res. 23:873-881.
23. Paton, J. F., and H. Waki. 2009. Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci. Biobehav. Rev. 33:89-94.
24. Proenca, A. R., R. A. Sertie, A. C. Oliveira, A. B. Campaaa, R. O. Caminhotto, P. Chimin, et al. 2014. New concepts in white adipose tissue physiology. Braz. J. Med. Biol. Res. 47:192-205.
25. Ribeiro, M. M., I. C. Trombetta, L. T. Batalha, M. U. Rondon, C. L. Forjaz, A. C. Barretto, et al. 2001. Muscle sympathetic nerve activity and hemodynamic alterations in middle-aged obese women. Braz. J. Med. Biol. Res. 34:475-478.
26. Smith, M. M., and C. T. Minson. 2012. Obesity and adipokines: effects on sympathetic overactivity. J. Physiol. 590:1787-1801.
27. Sundlof, G., and B. G. Wallin. 1977. The variability of muscle nerve sympathetic activity in resting recumbent man. J. Physiol. 272:383-397.
28. Sundlof, G., and B. G. Wallin. 1978. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J. Physiol. 274:621-637.
29. Taddei, S., A. Virdis, P. Mattei, and A. Salvetti. 1993. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21:929-933.
30. Taddei, S., A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti. 1997. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 29:274-279.
31. Takagishi, M., H. Waki, M. E. Bhuiyan, S. S. Gouraud, A. Kohsaka, H. Cui, et al. 2010. IL-6 microinjected in the nucleus tractus solitarii attenuates cardiac baroreceptor reflex function in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298:R183-R190.
32. Trayhurn, P., and I. S. Wood. 2004. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92:347-355.
33. Van Guilder, G. P., G. L. Hoetzer, D. R. Dengel, B. L. Stauffer, and C. A. DeSouza. 2006. Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans. J. Cardiovasc. Pharmacol. 47:310-313.
34. Waki, H., S. S. Gouraud, M. Maeda, and J. F. R. Paton. 2008. Gene expression profiles of major cytokines in the nucleus tractus solitarii of the spontaneously hypertensive rat. Auton. Neurosci. 142:40-44.
35. Wesseling, K. H., J. R. Jansen, J. J. Settels, and J. J. Schreuder. 1993. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. J. Appl. Physiol. 74:2566-2573.
36. Young, J. B., and I. A. Macdonald. 1992. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int. J. Obes. Relat. Metab. Disord. 16:959-967.
37. Zubcevic, J., H. Waki, M. K. Raizada, and J. F. Paton. 2011. Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 57:1026-1033.